vTv Therapeutics (VTVT) Retained Earnings (2015 - 2026)
vTv Therapeutics (VTVT) reported Retained Earnings of -$302.6 million for Q1 2026, up 0.74% on a YoY basis from -$300.3 million in Q1 2025, and up 7.39% sequentially from -$326.7 million in Q4 2025.
vTv Therapeutics (VTVT) Retained Earnings (2015 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 12 years of Retained Earnings data on file, last reported at -$302.6 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 0.74% year-over-year to -$302.6 million; the trailing twelve-month figure through Mar 2026 stood at -$302.6 million (up 0.74% YoY), and the FY2025 full-year result was -$326.7 million, down 9.0% from the prior year.
- Retained Earnings improved to -$302.6 million in Q1 2026, from -$326.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$247.7 million in Q1 2022 to a low of -$326.7 million in Q4 2025.
- A 5-year average of -$287.6 million and a median of -$286.1 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings increased 9.85% in 2022 and slipped 10.86% in 2023, its largest moves.
- Tracing VTVT's Retained Earnings over 5 years: stood at -$265.5 million in 2022, then fell by 5.84% to -$281.0 million in 2023, then retreated by 6.65% to -$299.7 million in 2024, then decreased by 9.0% to -$326.7 million in 2025, then gained by 7.39% to -$302.6 million in 2026.
- Business Quant data shows VTVT's Retained Earnings at -$302.6 million in Q1 2026, -$326.7 million in Q4 2025, and -$319.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | -302.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302.56 Mn |
| Dec 31, 2025 | -326.69 Mn |
| Sep 30, 2025 | -319.60 Mn |
| Jun 30, 2025 | -310.90 Mn |
| Mar 31, 2025 | -304.80 Mn |
| Dec 31, 2024 | -299.72 Mn |
| Sep 30, 2024 | -296.10 Mn |
| Jun 30, 2024 | -291.30 Mn |
| Mar 31, 2024 | -286.12 Mn |
| Dec 31, 2023 | -281.04 Mn |
| Sep 30, 2023 | -281.20 Mn |
| Jun 30, 2023 | -280.81 Mn |
| Mar 31, 2023 | -274.32 Mn |
| Dec 31, 2022 | -265.52 Mn |
| Sep 30, 2022 | -267.10 Mn |
| Jun 30, 2022 | -253.30 Mn |
| Mar 31, 2022 | -247.66 Mn |
| Dec 31, 2021 | -248.83 Mn |
| Sep 30, 2021 | -259.00 Mn |
| Jun 30, 2021 | -273.10 Mn |